These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
970 related items for PubMed ID: 25888317
1. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC. BMC Infect Dis; 2015 Feb 15; 15():62. PubMed ID: 25888317 [Abstract] [Full Text] [Related]
2. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology. Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC. PLoS One; 2015 Feb 15; 10(7):e0133756. PubMed ID: 26222142 [Abstract] [Full Text] [Related]
5. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda. Nakiyingi L, Bwanika JM, Kirenga B, Nakanjako D, Katabira C, Lubega G, Sempa J, Nyesiga B, Albert H, Manabe YC. PLoS One; 2013 Feb 15; 8(9):e74023. PubMed ID: 24040151 [Abstract] [Full Text] [Related]
6. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing. Peter J, Theron G, Chanda D, Clowes P, Rachow A, Lesosky M, Hoelscher M, Mwaba P, Pym A, Dheda K, TB-NEAT team. BMC Infect Dis; 2015 Jul 09; 15():262. PubMed ID: 26156025 [Abstract] [Full Text] [Related]
8. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. J Acquir Immune Defic Syndr; 2009 Oct 01; 52(2):145-51. PubMed ID: 19692904 [Abstract] [Full Text] [Related]
11. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, Freedberg KA, Bassett IV. BMC Infect Dis; 2014 Feb 26; 14():110. PubMed ID: 24571362 [Abstract] [Full Text] [Related]
13. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. Lawn SD, Kerkhoff AD, Vogt M, Wood R. AIDS; 2012 Aug 24; 26(13):1635-43. PubMed ID: 22555166 [Abstract] [Full Text] [Related]
19. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial. Agizew T, Chihota V, Nyirenda S, Tedla Z, Auld AF, Mathebula U, Mathoma A, Boyd R, Date A, Pals SL, Lekone P, Finlay A. BMC Infect Dis; 2019 Dec 16; 19(1):1058. PubMed ID: 31842773 [Abstract] [Full Text] [Related]
20. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A. PLoS One; 2010 Mar 24; 5(3):e9848. PubMed ID: 20352098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]